— Know what they know.
Not Investment Advice
Also trades as: EPRX.TO (TSX) · $vol 0M · EPRXF (OTC) · $vol 0M

EPRX NASDAQ

Eupraxia Pharmaceuticals Inc.
1W: -9.6% 1M: -2.8% 3M: +11.0% YTD: -4.4% 1Y: +19.3%
$7.24
-0.59 (-7.54%)
 
Weekly Expected Move ±12.5%
$5 $6 $7 $8 $9
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 44 · $242.4M mcap · 26M float · 1.68% daily turnover · Short 54% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
34.1 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 8742.2%
Cost Advantage
33
Intangibles
25
Switching Cost
43
Network Effect
43
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. EPRX has No discernible competitive edge (34.1/100). The business operates without significant structural advantages. The primary source of advantage is Switching Costs. ROIC of 8742.2% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$11
Low
$18
Avg Target
$25
High
Based on 3 analysts since Aug 11, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 2Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$17.67
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-01 H.C. Wainwright Brandon Folkes Initiated $11 — +20.9% $9.10
2026-09-24 Wedbush — Initiated $17 — +108.8% $8.14
2026-09-24 Stifel Nicolaus Samimy Annabel Initiated $25 — +207.1% $8.14
2026-06-25 Oppenheimer — Initiated $17 — +165.2% $6.41
2026-01-15 Cantor Fitzgerald — Initiated $19 — +125.4% $8.43

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
3
ROE
1
ROA
1
D/E
2
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. EPRX receives an overall rating of C. Areas of concern: ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-01 C+ C
2026-05-20 C C+
2026-05-14 C+ C
2026-05-04 C C+
2026-04-01 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
85
Earnings Quality
32
Growth
—
Value
29
Momentum
—
Safety
100
Cash Flow
—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
23.60
Safe Zone
Piotroski F-Score
3/9
✗ ✗ ✓ ✓ ✗ ✓ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
-1.92
Bankruptcy prob: 12.8%
Moderate
Credit Rating
A+
Score: 75.7/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.70x
Accruals: -19.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. EPRX scores 23.60, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. EPRX scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. EPRX's implied 12.8% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. EPRX receives an estimated rating of A+ (score: 75.7/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-7.10x
PEG
0.32x
P/S
0.00x
P/B
3.66x
P/FCF
-11.55x
P/OCF
—
EV/EBITDA
-5.85x
EV/Revenue
—
EV/EBIT
-5.81x
EV/FCF
-8.08x
Earnings Yield
-12.04%
FCF Yield
-8.66%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. EPRX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.001
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
—
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.063
Assets / Equity
=
ROE
-68.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. EPRX's ROE of -68.6% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 626 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$7.24
Median 1Y
$8.44
5th Pctile
$2.61
95th Pctile
$27.48
Ann. Volatility
64.6%
Analyst Target
$17.67
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
—
Revenue / Employee
—
Profit / Employee
—
NI: $-53,858,075
SGA / Employee
—
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -55.4% -1.7% -81.1% -1.3% -2.2% -61.1% -64.6% -60.3% -68.6% -68.64%
ROA -32.9% -1.6% -77.5% -1.3% -1.7% -59.3% -61.6% -57.4% -64.6% -64.58%
ROIC 1.9% -14.5% -59.4% -25.2% -11.4% -21.2% -16.7% -45.9% 87.4% 87.42%
ROCE -59.2% -2.0% -84.4% -1.4% -1.9% -33.5% -42.7% -36.3% -40.2% -40.18%
Gross Margin — — — — — — — — — —
Operating Margin — — — — — — — — — —
Net Margin — — — — — — — — — —
EBITDA Margin — — — — — — — — — —
FCF Margin — — — — — — — — — —
OCF Margin — — — — — — — — — —
ROE 3Y Avg snapshot only -91.59%
ROA 3Y Avg snapshot only -80.63%
ROIC Economic snapshot only -35.56%
Cash ROA snapshot only -26.60%
Valuation
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio — — — — — — -8.33 -8.19 -8.30 -7.103
P/S Ratio — — — — — — — — — 0.000
P/B Ratio — — — — — — 3.49 2.98 3.34 3.661
P/FCF — — — — — — -13.39 -12.27 -11.55 -11.554
P/OCF — — — — — — — — — —
EV/EBITDA — — — — — — -6.03 -5.49 -5.85 -5.851
EV/Revenue — — — — — — — — — —
EV/EBIT — — — — — — -5.99 -5.46 -5.81 -5.812
EV/FCF — — — — — — -9.63 -8.18 -8.08 -8.081
Earnings Yield — — — — — — -12.0% -12.2% -12.0% -12.04%
FCF Yield — — — — — — -7.5% -8.1% -8.7% -8.66%
PEG Ratio snapshot only 0.322
Price/Tangible Book snapshot only 3.341
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.11 4.17 11.10 13.00 8.72 23.98 15.12 19.30 16.00 15.999
Quick Ratio 2.11 4.17 11.10 13.00 8.72 23.98 15.12 19.30 16.00 15.999
Debt/Equity 0.31 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.014
Net Debt/Equity -1.26 -0.90 -0.99 -0.96 -0.87 -0.99 -0.98 -0.99 -1.00 -1.004
Debt/Assets 0.19 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.013
Debt/EBITDA -0.59 -0.01 -0.00 -0.00 -0.00 -0.01 -0.00 -0.04 -0.04 -0.035
Net Debt/EBITDA 2.37 0.54 1.24 0.76 0.49 3.03 2.36 2.75 2.51 2.514
Interest Coverage -20.53 -41.56 -69.57 -94.51 -50061.76 -209302.46 — — — —
Equity Multiplier 1.68 1.09 1.05 1.02 1.05 1.03 1.05 1.05 1.07 1.066
Cash Ratio snapshot only 15.631
Cash to Debt snapshot only 72.527
FCF to Debt snapshot only -20.598
Defensive Interval snapshot only 814.2 days
Efficiency & Turnover
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover — — — — — — — — — —
Receivables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Payables Turnover — — — — — 0.03 — 0.02 0.02 0.021
DSO — — — — — — — — — —
DIO — — — — — 0 0 0 0 0.0 days
DPO — — — — — 10916 0 15037 17591 17591.0 days
Cash Conversion Cycle — — — — — — — — — —
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — — — — — — —
Net Income — — — — -3.9% -1.5% -73.9% -36.5% -30.5% -30.46%
EPS — — — — -3.9% -1.4% -19.3% 14.1% 29.3% 29.25%
FCF — — — — -3.0% -40.7% -22.3% -11.0% -22.6% -22.60%
EBITDA — — — — -4.1% -1.6% -75.2% -37.5% -30.1% -30.07%
Op. Income — — — — -3.5% -1.4% -67.0% -38.0% -47.0% -47.01%
OCF Growth snapshot only -21.84%
Asset Growth snapshot only 4.92%
Equity Growth snapshot only 4.81%
Debt Growth snapshot only 51.45%
Shares Change snapshot only 84.40%
Growth Quality
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — — — 1.00 1.000
Earnings Stability — — — — — — — — 0.94 0.938
Margin Stability — — — — — — — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.88 0.878
Earnings Smoothness — — — — — — — — — —
ROE Trend — — — — — — — — 0.77 0.770
Gross Margin Trend — — — — — — — — — —
FCF Margin Trend — — — — — — — — — —
Sustainable Growth Rate — — — — — — — — — —
Internal Growth Rate — — — — — — — — — —
Cash Flow Quality
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.94 1.10 0.88 0.81 0.75 0.60 0.61 0.65 0.70 0.705
FCF/OCF 1.00 1.00 1.00 1.01 1.01 1.02 1.02 1.02 1.02 1.020
FCF/Net Income snapshot only 0.719
CapEx/Revenue — — — — — — — — — —
CapEx/Depreciation snapshot only 2.160
Accruals Ratio -0.02 0.15 -0.09 -0.23 -0.41 -0.24 -0.24 -0.20 -0.19 -0.191
Sloan Accruals snapshot only 1.316
Cash Flow Adequacy snapshot only -49.619
Dividends & Buybacks
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield — — — — — — 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — —
Total Payout Ratio — — — — — — — — — —
Div. Increase Streak — — — — — — — — — —
Chowder Number — — — — — — — — — —
Buyback Yield — — — — — — 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield — — — — — — -19.2% -34.8% -34.4% -34.39%
Total Shareholder Return — — — — — — -19.2% -34.8% -34.4% -34.39%
DuPont Factors
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.99 0.99 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.001
Interest Burden (EBT/EBIT) 1.05 1.02 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.000
EBIT Margin — — — — — — — — — —
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.68 1.09 1.05 1.02 1.30 1.03 1.05 1.05 1.06 1.063
Per Share
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.23 $-0.46 $-0.76 $-1.03 $-1.13 $-1.12 $-0.91 $-0.88 $-0.80 $-0.80
Book Value/Share $0.42 $0.27 $0.94 $0.80 $0.63 $3.39 $2.16 $2.43 $1.98 $1.95
Tangible Book/Share $0.42 $0.27 $0.94 $0.80 $0.63 $3.39 $2.16 $2.43 $1.98 $1.98
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-0.22 $-0.50 $-0.67 $-0.84 $-0.86 $-0.68 $-0.56 $-0.59 $-0.57 $-0.55
OCF/Share $-0.22 $-0.50 $-0.67 $-0.84 $-0.85 $-0.67 $-0.55 $-0.58 $-0.56 $-0.54
Cash/Share $0.65 $0.24 $0.93 $0.77 $0.55 $3.36 $2.12 $2.45 $2.01 $2.02
EBITDA/Share $-0.22 $-0.45 $-0.75 $-1.02 $-1.12 $-1.11 $-0.90 $-0.88 $-0.79 $-0.79
Debt/Share $0.13 $0.00 $0.00 $0.00 $0.00 $0.01 $0.00 $0.04 $0.03 $0.03
Net Debt/Share $-0.52 $-0.24 $-0.93 $-0.77 $-0.55 $-3.35 $-2.12 $-2.41 $-1.99 $-1.99
Academic Models
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — 23.600
Altman Z-Prime snapshot only 43.893
Piotroski F-Score 2 1 2 2 3 4 4 3 3 3
Beneish M-Score — — — — — — — — — —
Ohlson O-Score snapshot only -1.916
ROIC (Greenblatt) snapshot only -40.20%
Net-Net WC snapshot only $1.91
Credit
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A+
Credit Score 47.65 49.87 49.81 50.34 50.06 49.94 75.71 75.74 75.70 75.703
Credit Grade snapshot only 5
Credit Trend snapshot only 25.648
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 71

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms